West Pharmaceutical Services Inc

WST.US
Healthcare · Medical Instruments & Supplies
337.00
+5.75 (+1.74%)
USD · NYSE

Company Information

Company Name
West Pharmaceutical Services Inc
Sector
Healthcare
Industry
Medical Instruments & Supplies
Exchange
NYSE
ISIN: US9553061055
CIK: 0000105770
CUSIP: 953348109
Currency: USD
Full Time Employees: 10,800
Phone: 610 594 2900
Fiscal Year End: December
IPO Date: Jan 13, 1978
Description:

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging products. This segment also provides drug containment solutions in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. This segment primarily serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.

Address:

530 Herman O. West Drive, Exton, PA, United States, 19341-1147

People

Directors & Officers

Name Title Year Born
Mr. Eric Mark Green Non-Independent Chair of the Board, President & CEO 1970
Mr. Robert W. McMahon C.M.A. Senior VP & CFO 1969
Ms. Annette F. Favorite Chief HR Officer & Senior VP 1965
Mr. Shane A. Campbell SVP & Chief Proprietary Segment Officer 1981
Mr. Chad R. Winters VP of Finance & Chief Accounting Officer 1979
Dr. Devesh Mathur Senior VP & CTO NA
Mr. John P. Sweeney C.F.A. Vice President of Investor Relations NA
Mr. Norman D. Finch Jr. Senior VP, General Counsel & Corporate Secretary 1965
Ms. Michele Polinsky Vice President of Global Communications NA
Mr. Rudy J. Poussot Senior Vice President of Strategy & Corporate Development 1970

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Feb 05, 2026 Ro Khanna N/A Sale N/A $231.83 N/A
Jan 29, 2026 Ro Khanna N/A Purchase N/A $232.20 N/A
Jul 22, 2025 Lisa C. McClain N/A Sale N/A $218.46 N/A
Jun 17, 2025 Lisa C. McClain N/A Purchase N/A $218.18 N/A
May 19, 2025 Ro Khanna N/A Purchase N/A $217.00 N/A
Apr 23, 2025 Ro Khanna N/A Purchase N/A $217.48 N/A
Apr 08, 2025 Robert Bresnahan, Jr. N/A Sale N/A $190.12 N/A
Feb 25, 2025 Robert Bresnahan, Jr. N/A Purchase N/A $220.34 N/A
Feb 13, 2025 Jared Moskowitz N/A Sale N/A $199.40 N/A
Nov 08, 2024 Jared Moskowitz N/A Sale N/A $323.90 N/A
Oct 29, 2024 Charles Witherspoon N/A Sale 703.00 $310.40 $218.21K
Aug 19, 2024 Charles Witherspoon N/A Sale 1.03K $300.00 $308.70K
Jun 12, 2024 Silji Abraham N/A Sale 1.80K $330.78 $595.40K
May 10, 2024 Thomas W Hofmann N/A Sale 617.00 $365.92 $225.77K
May 07, 2024 Eric Mark Green N/A Sale 66.00K $366.65 $24.20M
Mar 11, 2024 Chad Winters N/A Sale 815.00 $358.82 $292.44K
Feb 28, 2024 Charles Witherspoon N/A Sale 2.02K $358.62 $724.05K
Feb 27, 2024 Eric Mark Green N/A Sale 64.13K $359.85 $23.08M
Feb 23, 2024 Silji Abraham N/A Sale 7.01K $365.00 $2.56M
Dec 28, 2023 Jared Moskowitz N/A Purchase N/A $354.93 N/A

Shareholders

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Vanguard Group Inc 9.54M Dec 31, 2025 13.55% $0.04 -1.71%
BlackRock Inc 6.84M Mar 31, 2026 9.71% $0.03 3.59%
Vanguard Capital Management, LLC 4.68M Mar 31, 2026 6.65% $0.03 0.00%
Vanguard Portfolio Management, LLC 4.09M Mar 31, 2026 5.82% $0.05 0.00%
State Street Corp 3.29M Mar 31, 2026 4.68% $0.03 1.28%
Artisan Partners Limited Partnership 2.66M Mar 31, 2026 3.78% $1.07 -6.75%
Bank of New York Mellon Corp 2.47M Mar 31, 2026 3.50% $0.11 -7.37%
T. Rowe Price Investment Management,Inc. 2.34M Mar 31, 2026 3.32% $0.40 18.94%
Generation Investment Management LLP 2.24M Mar 31, 2026 3.19% $5.04 43.67%
Geode Capital Management, LLC 1.91M Mar 31, 2026 2.72% $0.03 2.32%
Morgan Stanley - Brokerage Accounts 1.46M Mar 31, 2026 2.07% $0.02 -4.80%
Brown Advisory Holdings Inc 1.34M Mar 31, 2026 1.90% $0.55 -31.01%
Longview Partners (Guernsey) Limited 1.32M Mar 31, 2026 1.87% $4.67 16.30%
APG Asset Management 1.27M Mar 31, 2026 1.80% $0.87 5.69%
Apg All Pensions Group 1.27M Mar 31, 2026 1.80% $0.87 5.69%
FMR Inc 1.25M Mar 31, 2026 1.78% $0.02 1,039.72%
Amvescap Plc. 1.06M Mar 31, 2026 1.50% $0.03 16.22%
JPMorgan Chase & Co 1.04M Mar 31, 2026 1.48% $0.02 279.48%
NORGES BANK 988.74K Dec 31, 2025 1.40% $0.03 7.73%
UBS Asset Mgmt Americas Inc 902.76K Mar 31, 2026 1.28% $0.05 -0.32%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Vanguard Total Stock Mkt Idx Inv 2.24M 3.19% ▼ 2.15% Jun 30, 2026
2 Vanguard 500 Index Investor 1.83M 2.61% ▼ 2.60% Jun 30, 2026
3 Vanguard Mid Cap Index Institutional 1.53M 2.17% ▼ 2.02% Jun 30, 2026
4 iShares Core S&P 500 ETF 974.77K 1.38% ▲ 0.32% Jun 30, 2026
5 Vanguard Growth Index Investor 939.60K 1.33% ▼ 4.93% Jun 30, 2026
6 Fidelity 500 Index 920.66K 1.31% ▼ 0.14% May 31, 2026
7 T. Rowe Price US Mid-Cap Growth Equity 894.79K 1.27% ▼ 15.64% Jun 30, 2026
8 T. Rowe Price Mid-Cap Growth 894.79K 1.27% ▼ 15.61% Jun 30, 2026
9 State Street® SPDR® S&P 500® ETF 853.85K 1.21% ▼ 1.29% Jun 30, 2026
10 Six Circles Mgd Eq Port US Uncons 742.78K 1.06% ▲ 235.84% Mar 31, 2026

Financial Highlights

Market Cap: $23.72B
EBITDA: $912.20M
P/E Ratio: $42.39
PEG Ratio: $2.84
Book Value: $42.18
Dividend/Share: $0.87
Dividend Yield: 0.26%
Earnings/Share: $7.95
Profit Margin: 16.98%
Operating Margin: 22.47%
ROA (TTM): 11.38%
ROE (TTM): 19.09%
Revenue (TTM): $3.33B
Revenue/Share (TTM): $46.30
Earnings Growth (YOY): 18.10%
Revenue Growth (YOY): 13.80%

Valuation Metrics

Enterprise Value: $23.19B
Trailing P/E: 42.39
Forward P/E: 37.45

Shares Statistics

Shares Outstanding: 70.38M
Shares Float: 69.89M
% Insiders: 63.80%
% Institutions: 10,415.20%
Short % Float: 3.92%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

Open full waterfall
Line Item
Step Type
Value
Revenue
adjust
$3.07B
Cost of Goods Sold
adjust
$-1.97B
Gross Profit
subtotal
$1.10B
SG&A
adjust
$-388.70M
R&D
adjust
$-74.30M
Other Operating Expense
adjust
$-22.90M
Operating Income
subtotal
$617.40M
Other / Non-Operating Items
adjust
$-123.70M
Net Income
subtotal
$493.70M

Earnings Per Share (EPS) History

Financial Ratios

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about WST.US!